Effect of Postoperative Administration of Saireito for Bilateral Chronic Subdural Hematomas
Copyright © 2011 SciRes. IJCM
288
B-CSDH, saireito administration may prevent sympto-
matic deterioration of a contralateral low-density CSDH,
preempting subsequent surgery.
REFERENCES
[1] M. Miyagami and Y. Kagawa, “Effectiveness of Kampo
Medicine Gorei-San for Chronic Subdural Hematoma,”
No Shinkei Geka, Vol. 37, No. 8, 2009, pp. 765-770.
(Japanese, with English abstract)
[2] M. Muramatsu, T. Yoshikawa and K. Hanabusa, “Effec-
tiveness of Kampo Medicine Gorei-San-Ryo for Chronic
Subdural Hematoma in very Elderly Patients,” No Shinkei
Geka, Vol. 33, No. 10, 2005, pp. 965-969. (Japanese,
with English abstract)
[3] T. F. Sun, R. Boet and W. S. Poon, “Non-surgical Pri-
mary Treatment of Chronic Subdural Haematoma: Pre-
liminary Results of Using Dexamethasone,” British
Journal of Neurosurgery, Vol. 19, No. 4, 2005, pp. 327-
333. doi:10.1080/02688690500305332
[4] J. L. Voelker, “Nonoperative Treatment of Chronic Sub-
dural Hematoma,” Neurosurgery Clinics of North Amer-
ica, Vol. 11, No. 3, 2000, pp. 507-513.
[5] S. Zarkou, M. I. Aguilar, N. P. Patel, K. E. Wellik, D. M.
Wingerchuk and B. M. Demaerschalk, “The Role of Cor-
ticosteroids in the Management of Chronic Subdural He-
matomas: A Critically Appraised Topic,” Neurologist,
Vol. 15, No. 5, 2009, pp. 299-302.
doi:10.1097/NRL.0b013e3181b65558
[6] I. Iwai, T. Suda, F. Tozawa, Y. Nakano, Y. Sato, N. Oh-
mori, T. Sumitomo, M. Yamada and H. Demura, “Stimu-
latory Effect of Saireito on Proopiomelanocortin Gene
Expression in the Rat Anterior Pituitary Gland,” Neuro-
science Letters, Vol. 157, No. 1, 1993, pp. 37-40.
doi:10.1016/0304-3940(93)90637-Z
[7] Y. Nakano, T. Suda, F. Tozawa, I. Dobashi, Y. Sato, N.
Ohmori, T. Sumitomo and H. Demura, “Saireito (A Chi-
nese Herbal Drug)-Stimulated Secretion and Synthesis of
Pituitary ACTH Are Mediated by Hypothalamic Cortico-
tropin-Releasing Factor,” Neuroscience Letters, Vol. 160,
No. 1, 1993, pp. 93-95.
doi:10.1016/0304-3940(93)90921-7
[8] K. S. Lee, “Natural History of Chronic Subdural Haema-
toma,” Brain Injury, Vol. 18, No. 4, 2004, pp. 351-358.
doi:10.1080/02699050310001645801
[9] T. H. Tsai, A. S. Lieu, S. L. Hwang, T. Y. Huang and Y.
F. Hwang, “A Comparative Study of the Patients with
Bilateral or Unilateral Chronic Subdural Hematoma: Pre-
cipitating Factors and Postoperative Outcomes,” Journal
of Trauma. Vol. 68, No. 3, 2010, pp. 571-575.
doi:10.1097/TA.0b013e3181a5f31c
[10] H. J. Hong, Y. J. Kim, H. J. Yi, Y. Ko, S. J. Oh and J. M.
Kim, “Role of Angiogenic Growth Factors and Inflam-
matory Cytokine on Recurrence of Chronic Subdural
Hematoma,” Surgical Neurology, Vol. 71, No. 2, 2009,
pp. 161-166. doi:10.1016/j.surneu.2008.01.023
[11] H. Fujisawa, S. Nomura, E. Tsuchida and H. Ito, “Serum
Protein Exudation in Chronic Subdural Haematomas: A
Mechanism for Haematoma Enlargement?” Acta Neuro-
chirungica Supplements (Wien), Vol. 140, No. 2, 1998,
pp. 161-166. doi:10.1007/s007010050077
[12] C. K. Park, K. H. Choi, M. C. Kim, J. K. Kang and C. R.
Choi, “Spontaneous Evolution of Posttraumatic Subdural
Hygroma into Chronic Subdural Haematoma,” Acta
Neurochirungica Supplements (Wien), Vol. 127, No. 1-2,
1994, pp. 41-47. doi:10.1007/BF01808545
[13] S. H. Park, S. H. Lee, J. Park, J. H. Hwang, S. K. Hwang
and I. S. Hamm, “Chronic Subdural Hematoma Preceded
by Traumatic Subdural Hygroma,” Journal of Clinical
Neuroscience, Vol. 15, No. 8, 2008, pp. 868-872.
doi:10.1016/j.jocn.2007.08.003
[14] T. Ono, N. Liu, T. Makino, F. Nogaki, E. Muso, G.
Honda and T. Kita, “Suppressive Mechanisms of Sairei-to
on Mesangial Matrix Expansion in Rat Mesangioprolif-
erative Glomerulonephritis,” Nephron Experimental Ne-
phrology, Vol. 100, No. 3, 2005, pp. e132-e142.
doi:10.1159/000085059